Surgery Experts

John C. Moore

STAAR Surgical Company
United States of America


From December 2012 through March 2016, Mr. Moore served as Chairman of the Board of Directors of Optovue, Inc., an ophthalmic medical device company and he remains an Optovue director. Since May 2014 Mr. Moore has also served as Chief Technical Officer of TearSolutions, L.L.C., a company focused on a natural replacement therapy for dry eyes. Between April 2005 and January 2007, Mr. Moore served as Chief Executive Officer of Notal Vision, an Israel based ophthalmic company that develops diagnostic solutions for the early detection and monitoring of age related macular degeneration (AMD). Mr. Moore served as the President and Chief Executive Officer of Laser Diagnostic Technologies, a manufacturer of ophthalmic diagnostic laser devices used for the early detection of glaucoma, from 2000 until 2004 when it was acquired by Carl Zeiss Meditec, Inc. Before this, Mr. Moore was a vice president at Alcon Laboratories, one of the largest companies in the ophthalmic surgical sector, where he was responsible for pursuing and executing strategic acquisitions and partnerships to broaden that company’s product portfolio. Mr. Moore also spent more than 10 years in various roles at Carl Zeiss, Inc., a multinational ophthalmic company with primary businesses in optics, medical, scientific and semiconductor products. Mr. Moore received his B.S. in General Science from University of Rochester. John C. Moore is an “independent director,” as that term is defined under Rule 5605(a)(2) of the Nasdaq Stock Market.

Research Interest


Global Experts from United States of America

Global Experts in Subject

Share This Profile